Journal
NATURE COMMUNICATIONS
Volume 13, Issue 1, Pages -Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41467-022-28559-3
Keywords
-
Categories
Funding
- NIH [R01GM116961, NS111745, MH085926, F32MH121061, T32GM135131]
- Robertson funds at Cold Spring Harbor Laboratory
- Doug Fox Alzheimer's fund
- Austin's purpose
- Heartfelt Wing Alzheimer's fund
- Gertrude and Louis Feil Family Trust
- Johns Hopkins Catalyst Award
Ask authors/readers for more resources
This study reports the identification of a functional antibody that specifically targets and regulates the ion channel activity of the GluN1-GluN2B subtype of NMDA receptors. The findings suggest that antibodies can serve as specific reagents for modulating NMDA receptor functions, which has important implications for both basic research and therapeutic applications.
Selective targeting individual subtypes of N-methyl-D-aspartate receptors (NMDARs) is a desirable therapeutic strategy for neurological disorders. Here, the authors report identification of a functional antibody that specifically targets and allosterically down-regulates ion channel activity of the GluN1-GluN2B NMDAR subtype. N-methyl-D-aspartate receptors (NMDARs) are critically involved in basic brain functions and neurodegeneration as well as tumor invasiveness. Targeting specific subtypes of NMDARs with distinct activities has been considered an effective therapeutic strategy for neurological disorders and diseases. However, complete elimination of off-target effects of small chemical compounds has been challenging and thus, there is a need to explore alternative strategies for targeting NMDAR subtypes. Here we report identification of a functional antibody that specifically targets the GluN1-GluN2B NMDAR subtype and allosterically down-regulates ion channel activity as assessed by electrophysiology. Through biochemical analysis, x-ray crystallography, single-particle electron cryomicroscopy, and molecular dynamics simulations, we show that this inhibitory antibody recognizes the amino terminal domain of the GluN2B subunit and increases the population of the non-active conformational state. The current study demonstrates that antibodies may serve as specific reagents to regulate NMDAR functions for basic research and therapeutic objectives.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available